Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Macular Degeneration”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Not applicableStudy completedNCT01790958
What this trial is testing

Microcurrent Stimulation to Treat Macular Degeneration

Who this might be right for
Retinal DiseasesStargardt's DiseaseRetinitis Pigmentosa
Retina Institute of Hawaii 50
Early research (Phase 1)Study completedNCT00346853
What this trial is testing

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Who this might be right for
Macular Dystrophy, Corneal
University of Utah 10
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT06300476
What this trial is testing

Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)

Who this might be right for
Stargardt Disease 1
West China Hospital 9
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Testing effectiveness (Phase 2)Enrolling By InvitationNCT02402660
What this trial is testing

Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more
Alkeus Pharmaceuticals, Inc. 160
Not applicableNot Yet RecruitingNCT06908161
What this trial is testing

Functional Assessments in Vision Impairment

Who this might be right for
Retinitis Pigmentosa (RP)Diabetic Retinopathy (DR)Age Related Macular Degeneration (AMD)+2 more
Center for Eye Research Australia 45
Testing effectiveness (Phase 2)UnknownNCT04864496
What this trial is testing

Effects of Treatment With N- Acetylcysteine on Visual Outcomes in Patients With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Shahid Beheshti University of Medical Sciences 30
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Not applicableLooking for participantsNCT01432847
What this trial is testing

Cell Collection to Study Eye Diseases

Who this might be right for
Retinal DiseaseAMDRetinal Degeneration+1 more
National Eye Institute (NEI) 930
Not applicableStudy completedNCT02909985
What this trial is testing

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

Who this might be right for
Age Related Macular DegenerationRetinitis PigmentosaCongenital Stationary Night Blindness+1 more
University of New Mexico 21
Not applicableNot Yet RecruitingNCT07266584
What this trial is testing

Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration

Who this might be right for
Stargardt DiseaseRetinitis Pigmentosa (RP)Inherited Retinal Degeneration
Science Corporation 5
Testing effectiveness (Phase 2)Study completedNCT03364153
What this trial is testing

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Pharma Global Development, Inc. 121
Not applicableLooking for participantsNCT04658251
What this trial is testing

Study of New Mutations in Cone Disorders

Who this might be right for
Retinal Dystrophy, Cone-RodCone DystrophyCone Rod Dystrophy+1 more
University Hospital, Lille 20
Early research (Phase 1)Study completedNCT04246866
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more
Gemini Therapeutics, Inc. 12
Not applicableLooking for participantsNCT00874783
What this trial is testing

Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases

Who this might be right for
Neurodegenerative Disorders
Hadassah Medical Organization 120
Testing effectiveness (Phase 2)Looking for participantsNCT06942572
What this trial is testing

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy
Splice Bio 57
Testing effectiveness (Phase 2)Ended earlyNCT01367444
What this trial is testing

Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration

Who this might be right for
Stargardt's Disease
Sanofi 27
Not applicableStudy completedNCT04776031
What this trial is testing

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

Who this might be right for
Early Age Related Macular Degeneration (Disorder)
Lutronic Vision, Inc 31
Not applicableLooking for participantsNCT06375239
What this trial is testing

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Who this might be right for
Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more
Ray Therapeutics, Inc. 120
Load More Results